BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chou AJ, Geller DS, Gorlick R. Therapy for osteosarcoma: where do we go from here? Paediatr Drugs 2008;10:315-27. [PMID: 18754698 DOI: 10.2165/00148581-200810050-00005] [Cited by in Crossref: 179] [Cited by in F6Publishing: 160] [Article Influence: 12.8] [Reference Citation Analysis]
Number Citing Articles
1 Lu Y, Cao G, Lan H, Liao H, Hu Y, Feng H, Liu X, Huang P. Chondrocyte-derived Exosomal miR-195 Inhibits Osteosarcoma Cell Proliferation and Anti-Apoptotic by Targeting KIF4A in vitro and in vivo. Transl Oncol 2021;16:101289. [PMID: 34952333 DOI: 10.1016/j.tranon.2021.101289] [Reference Citation Analysis]
2 Zhang L, Lyer AK, Yang X, Kobayashi E, Guo Y, Mankin H, Hornicek FJ, Amiji MM, Duan Z. Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells. Int J Nanomedicine 2015;10:2913-24. [PMID: 25931818 DOI: 10.2147/IJN.S79143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
3 Liu X, Fundora KA, Zhou Z, Miller AL 2nd, Lu L. Composite Hydrogel Embedded with Porous Microspheres for Long-Term pH-Sensitive Drug Delivery. Tissue Eng Part A 2019;25:172-82. [PMID: 30152721 DOI: 10.1089/ten.TEA.2018.0071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Gao Z, Zhou S, Song H, Wang Y, He X. Nomograms for predicting overall survival and cancer-specific survival of chondroblastic osteosarcoma patients. J Surg Oncol 2020;122:1676-84. [PMID: 32862456 DOI: 10.1002/jso.26185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Chang X, Ma Z, Zhu G, Lu Y, Yang J. New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma. J Bone Oncol 2021;29:100372. [PMID: 34258182 DOI: 10.1016/j.jbo.2021.100372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huang YF, Lu L, Shen HL, Lu XX. LncRNA SNHG4 promotes osteosarcoma proliferation and migration by sponging miR-377-3p. Mol Genet Genomic Med 2020;8:e1349. [PMID: 32537941 DOI: 10.1002/mgg3.1349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
7 Ruan W, Wang P, Feng S, Xue Y, Li Y. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells. Tumour Biol 2016;37:4065-73. [PMID: 26486328 DOI: 10.1007/s13277-015-4256-7] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 9.7] [Reference Citation Analysis]
8 Moneo V, Serelde BG, Blanco-Aparicio C, Diaz-Uriarte R, Avilés P, Santamaría G, Tercero JC, Cuevas C, Carnero A. Levels of active tyrosine kinase receptor determine the tumor response to Zalypsis. BMC Cancer 2014;14:281. [PMID: 24758355 DOI: 10.1186/1471-2407-14-281] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
9 Chen Y, Zhang K, Li Y, Guo R, Zhang K, Zhong G, He Q. Oestrogen-related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1. J Cell Mol Med 2019;23:2115-24. [PMID: 30609256 DOI: 10.1111/jcmm.14123] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wang S, Gao H, Zuo J, Gao Z. Cyclooxygenase-2 expression correlates with development, progression, metastasis, and prognosis of osteosarcoma: a meta-analysis and trial sequential analysis. FEBS Open Bio 2019;9:226-40. [PMID: 30761249 DOI: 10.1002/2211-5463.12560] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
11 Yang X, Yang P, Shen J, Osaka E, Choy E, Cote G, Harmon D, Zhang Z, Mankin H, Hornicek FJ, Duan Z. Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925. Br J Cancer 2014;110:2896-904. [PMID: 24853187 DOI: 10.1038/bjc.2014.254] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
12 Bernardini G, Geminiani M, Gambassi S, Orlandini M, Petricci E, Marzocchi B, Laschi M, Taddei M, Manetti F, Santucci A. Novel smoothened antagonists as anti-neoplastic agents for the treatment of osteosarcoma. J Cell Physiol 2018;233:4961-71. [PMID: 29215700 DOI: 10.1002/jcp.26330] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ma Y, Ren Y, Han EQ, Li H, Chen D, Jacobs JJ, Gitelis S, O'Keefe RJ, Konttinen YT, Yin G, Li TF. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy. Biochem Biophys Res Commun 2013;431:274-9. [PMID: 23291185 DOI: 10.1016/j.bbrc.2012.12.118] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 8.3] [Reference Citation Analysis]
14 Duan Z, Choy E, Harmon D, Yang C, Ryu K, Schwab J, Mankin H, Hornicek FJ. Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines. Mol Cancer Ther 2009;8:2122-30. [PMID: 19638450 DOI: 10.1158/1535-7163.MCT-09-0115] [Cited by in Crossref: 59] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
15 Xu J, Guo W, Xie L. Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma? BMC Cancer 2018;18:987. [PMID: 30326879 DOI: 10.1186/s12885-018-4872-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Naviglio S. The possible use of inorganic phosphate in osteosarcoma therapy. Future Oncol. 2013;9:1249-1251. [PMID: 23654203 DOI: 10.2217/fon.13.95] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
17 Wang J, Gong M, Xiong Z, Zhao Y, Xing D. Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma. J Orthop Surg Res 2021;16:432. [PMID: 34225733 DOI: 10.1186/s13018-021-02578-0] [Reference Citation Analysis]
18 He M, Jiang L, Li B, Wang G, Wang J, Fu Y. Oxymatrine suppresses the growth and invasion of MG63 cells by up-regulating PTEN and promoting its nuclear translocation. Oncotarget 2017;8:65100-10. [PMID: 29029415 DOI: 10.18632/oncotarget.17783] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
19 Fang D, Yang H, Lin J, Teng Y, Jiang Y, Chen J, Li Y. 17β-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner. Biochem Biophys Res Commun 2015;457:500-6. [PMID: 25592968 DOI: 10.1016/j.bbrc.2014.12.114] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
20 Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev. 2014;40:523-532. [PMID: 24345772 DOI: 10.1016/j.ctrv.2013.11.006] [Cited by in Crossref: 634] [Cited by in F6Publishing: 633] [Article Influence: 70.4] [Reference Citation Analysis]
21 Jin Y, Peng D, Shen Y, Xu M, Liang Y, Xiao B, Lu J. MicroRNA-376c Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting to Transforming Growth Factor-Alpha. DNA and Cell Biology 2013;32:302-9. [DOI: 10.1089/dna.2013.1977] [Cited by in F6Publishing: 31] [Reference Citation Analysis]
22 Yi Q, Liu Z, Zhang K, Liu X, Wang L, Geng B, Xia Y. The role of long non-coding RNA BCAR4 in human cancers. Hum Cell 2021;34:1301-9. [PMID: 34041673 DOI: 10.1007/s13577-021-00556-6] [Reference Citation Analysis]
23 Cao S, Wang C, Ma H, Yin R, Zhu M, Shen W, Dai J, Shu Y, Xu L, Hu Z, Shen H. Genome-wide Association Study on Platinum-induced Hepatotoxicity in Non-Small Cell Lung Cancer Patients. Sci Rep 2015;5:11556. [PMID: 26100964 DOI: 10.1038/srep11556] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
24 Wang YH, Wang ZX, Qiu Y, Xiong J, Chen YX, Miao DS, De W. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits growth, reduces invasion, and enhances radiosensitivity in human osteosarcoma cells. Mol Cell Biochem 2009;327:257-66. [PMID: 19229591 DOI: 10.1007/s11010-009-0064-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
25 Tirino V, Paino F, Papaccio F, La Noce M, Papaccio G, Desiderio V. Stemness markers of osteosarcoma. Bone Cancer. Elsevier; 2015. pp. 205-11. [DOI: 10.1016/b978-0-12-416721-6.00018-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Yang D, Xu T, Fan L, Liu K, Li G. microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis. J Exp Clin Cancer Res 2020;39:201. [PMID: 32972441 DOI: 10.1186/s13046-020-01670-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Liang C, Yu X, Xiong N, Zhang Z, Sun Z, Dong Y. Pictilisib Enhances the Antitumor Effect of Doxorubicin and Prevents Tumor-Mediated Bone Destruction by Blockade of PI3K/AKT Pathway. Front Oncol 2020;10:615146. [PMID: 33659212 DOI: 10.3389/fonc.2020.615146] [Reference Citation Analysis]
28 Zhang Y, Cheng H, Li W, Wu H, Yang Y. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling. Int J Cancer 2019;145:1068-82. [PMID: 30761524 DOI: 10.1002/ijc.32207] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
29 Joo MW, Kang YK, Yoo CY, Cha SH, Chung YG. Prognostic significance of chemotherapy-induced necrosis in osteosarcoma patients receiving pasteurized autografts. PLoS One 2017;12:e0172155. [PMID: 28196121 DOI: 10.1371/journal.pone.0172155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
30 Rashed WM. C-MET as a potential target therapy toward personalized therapy in some pediatric tumors: An overview. Critical Reviews in Oncology/Hematology 2018;131:7-15. [DOI: 10.1016/j.critrevonc.2018.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
31 Wang Z, Chen X, Zhao Y, Jin Y, Zheng J. G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail. J Cancer Res Clin Oncol 2019;145:87-96. [DOI: 10.1007/s00432-018-2768-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
32 Wyatt LE, Kennedy MJ. Cisplatin-induced ototoxicity and the role of pharmacogenetic testing. J Pediatr Pharmacol Ther 2012;17:395-9. [PMID: 23411597 DOI: 10.5863/1551-6776-17.4.395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
33 Gorska M, Marino Gammazza A, Zmijewski MA, Campanella C, Cappello F, Wasiewicz T, Kuban-Jankowska A, Daca A, Sielicka A, Popowska U, Knap N, Antoniewicz J, Wakabayashi T, Wozniak M. Geldanamycin-induced osteosarcoma cell death is associated with hyperacetylation and loss of mitochondrial pool of heat shock protein 60 (hsp60). PLoS One 2013;8:e71135. [PMID: 24015183 DOI: 10.1371/journal.pone.0071135] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
34 Chen MW, Wu XJ. SLC25A22 Promotes Proliferation and Metastasis of Osteosarcoma Cells via the PTEN Signaling Pathway. Technol Cancer Res Treat 2018;17:1533033818811143. [PMID: 30482097 DOI: 10.1177/1533033818811143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
35 Spina A, Sorvillo L, Di Maiolo F, Esposito A, D’Auria R, Di Gesto D, Chiosi E, Naviglio S. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway. J Cell Physiol. 2013;228:198-206. [PMID: 22674530 DOI: 10.1002/jcp.24124] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
36 Duarte IF, Lamego I, Marques J, Marques MPM, Blaise BJ, Gil AM. Nuclear Magnetic Resonance (NMR) Study of the Effect of Cisplatin on the Metabolic Profile of MG-63 Osteosarcoma Cells. J Proteome Res 2010;9:5877-86. [DOI: 10.1021/pr100635n] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
37 Wang Y, Huang H, Li Y. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP. Artificial Cells, Nanomedicine, and Biotechnology 2019;47:1458-65. [DOI: 10.1080/21691401.2019.1601099] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
38 Liu X, He S, Wu H, Xie H, Zhang T, Deng Z. Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo. Environ Health Prev Med 2019;24:79. [PMID: 31864288 DOI: 10.1186/s12199-019-0835-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
39 Xu E, Ji Z, Jiang H, Lin T, Ma J, Zhou X. Hypoxia-Inducible Factor 1A Upregulates HMGN5 by Increasing the Expression of GATA1 and Plays a Role in Osteosarcoma Metastasis. Biomed Res Int 2019;2019:5630124. [PMID: 31930127 DOI: 10.1155/2019/5630124] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Mills LJ, Scott MC, Shah P, Cunanan AR, Deshpande A, Auch B, Curtin B, Beckman KB, Spector LG, Sarver AL, Subramanian S, Richmond TA, Modiano JF. Comparative analysis of genome-wide DNA methylation identifies patterns that associate with conserved transcriptional programs in osteosarcoma. Bone 2020;:115716. [PMID: 33127576 DOI: 10.1016/j.bone.2020.115716] [Reference Citation Analysis]
41 Cappadone C, Stefanelli C, Malucelli E, Zini M, Onofrillo C, Locatelli A, Rambaldi M, Sargenti A, Merolle L, Farruggia G, Graziadio A, Montanaro L, Iotti S. p53-dependent and p53-independent anticancer activity of a new indole derivative in human osteosarcoma cells. Biochem Biophys Res Commun 2015;467:348-53. [PMID: 26433123 DOI: 10.1016/j.bbrc.2015.09.154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
42 O'Day K, Gorlick R. Novel therapeutic agents for osteosarcoma. Expert Rev Anticancer Ther 2009;9:511-23. [PMID: 19374604 DOI: 10.1586/era.09.7] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
43 Chen C, Dong J, Chen H, Wang X, Mei J, Wang L, Xian CJ. Preparation of adriamycin gelatin microsphere-loaded decellularized periosteum that is cytotoxic to human osteosarcoma cells. J Cell Physiol 2019;234:10771-81. [PMID: 30480804 DOI: 10.1002/jcp.27753] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Zhang ZC, Tang C, Dong Y, Zhang J, Yuan T, Li XL. Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin. J Cancer 2018;9:71-80. [PMID: 29290771 DOI: 10.7150/jca.22113] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
45 Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H, Hornicek F. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther. 2011;10:1337-1345. [PMID: 21666078 DOI: 10.1158/1535-7163.mct-11-0096] [Cited by in Crossref: 178] [Cited by in F6Publishing: 107] [Article Influence: 16.2] [Reference Citation Analysis]
46 Yu M, Wan Y, Zou Q. Somatic mitochondrial DNA mutations in Chinese patients with osteosarcoma. Int J Exp Pathol 2013;94:126-32. [PMID: 23441585 DOI: 10.1111/iep.12015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
47 Zhou JJ, Gonzalez A, Lenox MW, Fossum TW, Frank RK, Simon J, Stearns S, Ruoff CM, Wendt RE, Akabani G. Dosimetry of a (90)Y-hydroxide liquid brachytherapy treatment approach to canine osteosarcoma using PET/CT. Appl Radiat Isot 2015;97:193-200. [PMID: 25638490 DOI: 10.1016/j.apradiso.2014.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Li C, Cheng Q, Liu J, Wang B, Chen D, Liu Y. Potent growth-inhibitory effect of TRAIL therapy mediated by double-regulated oncolytic adenovirus on osteosarcoma. Mol Cell Biochem 2012;364:337-44. [PMID: 22354724 DOI: 10.1007/s11010-012-1235-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
49 Fan S, Li X, Li L, Wang L, Du Z, Yang Y, Zhao J, Li Y. Silencing of carboxypeptidase E inhibits cell proliferation, tumorigenicity, and metastasis of osteosarcoma cells. Onco Targets Ther 2016;9:2795-803. [PMID: 27274275 DOI: 10.2147/OTT.S98991] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
50 Li Y, Nakka M, Kelly AJ, Lau CC, Krailo M, Barkauskas DA, Hicks JM, Man TK. p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma. Cancer Res 2016;76:4002-11. [PMID: 27197201 DOI: 10.1158/0008-5472.CAN-15-3189] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
51 Carina V, Costa V, Sartori M, Bellavia D, De Luca A, Raimondi L, Fini M, Giavaresi G. Adjuvant Biophysical Therapies in Osteosarcoma. Cancers (Basel) 2019;11:E348. [PMID: 30871044 DOI: 10.3390/cancers11030348] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
52 Wang X, Xu Y, Chen X, Xiao J. [ARTICLE WITHDRAWN] Dexmedetomidine Inhibits Osteosarcoma Cell Proliferation and Migration, and Promotes Apoptosis by Regulating miR-520a-3p. Oncol Res 2018;26:495-502. [PMID: 28653601 DOI: 10.3727/096504017X14982578608217] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
53 Han K, Chen X, Bian N, Ma B, Yang T, Cai C, Fan Q, Zhou Y, Zhao TB. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1. Oncotarget 2015;6:8875-89. [PMID: 25823925 DOI: 10.18632/oncotarget.3560] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 11.0] [Reference Citation Analysis]
54 Tang Y, Yang C, Guo Z, Fu Y, Yu X, Liu B, Zhou H, Wang J, Li W, Pang Q. P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA. Medicine (Baltimore) 2017;96:e6714. [PMID: 28489748 DOI: 10.1097/MD.0000000000006714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
55 Mao X, Jin Y, Feng T, Wang H, Liu D, Zhou Z, Yan Q, Yang H, Yang J, Yang J, Ye Y, Su Y, Zuo G. Ginsenoside Rg3 Inhibits the Growth of Osteosarcoma and Attenuates Metastasis through the Wnt/β-Catenin and EMT Signaling Pathway. Evid Based Complement Alternat Med 2020;2020:6065124. [PMID: 32733585 DOI: 10.1155/2020/6065124] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
56 Dou Y, Zhu K, Sun Z, Geng X, Fang Q. Screening of disorders associated with osteosarcoma by integrated network analysis. Biosci Rep 2019;39:BSR20190235. [PMID: 30936265 DOI: 10.1042/BSR20190235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
57 Ren HY, Zhang YH, Li HY, Xie T, Sun LL, Zhu T, Wang SD, Ye ZM. Prognostic role of hypoxia-inducible factor-1 alpha expression in osteosarcoma: a meta-analysis. Onco Targets Ther 2016;9:1477-87. [PMID: 27042116 DOI: 10.2147/OTT.S95490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
58 Brassesco MS, Pezuk JA, de Oliveira JC, Valera ET, de Oliveira HF, Scrideli CA, Umezawa K, Tone LG. Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl)methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro. Cancer Biother Radiopharm 2013;28:351-8. [PMID: 23350896 DOI: 10.1089/cbr.2012.1305] [Reference Citation Analysis]
59 Zhang Y, Yang J, Zhao N, Wang C, Kamar S, Zhou Y, He Z, Yang J, Sun B, Shi X, Han L, Yang Z. Progress in the chemotherapeutic treatment of osteosarcoma. Oncol Lett 2018;16:6228-37. [PMID: 30405759 DOI: 10.3892/ol.2018.9434] [Cited by in Crossref: 22] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
60 Li CH, Yu TB, Qiu HW, Zhao X, Zhou CL, Qi C. miR-150 is downregulated in osteosarcoma and suppresses cell proliferation, migration and invasion by targeting ROCK1. Oncol Lett 2017;13:2191-7. [PMID: 28454380 DOI: 10.3892/ol.2017.5709] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
61 Asnafi AA, Behzad MM, Ghanavat M, Shahjahani M, Saki N. Singe nucleotide polymorphisms in osteosarcoma: Pathogenic effect and prognostic significance. Experimental and Molecular Pathology 2019;106:63-77. [DOI: 10.1016/j.yexmp.2018.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
62 Zhang Y, Deng X, Lei T, Yu C, Wang Y, Zhao G, Luo X, Tang K, Quan Z, Jiang D. Capsaicin inhibits proliferation and induces apoptosis in osteosarcoma cell lines via the mitogen‑activated protein kinase pathway. Oncol Rep 2017;38:2685-96. [PMID: 29048662 DOI: 10.3892/or.2017.5960] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
63 Shimizu T, Kamel WA, Yamaguchi-Iwai S, Fukuchi Y, Muto A, Saya H. Calcitriol exerts an anti-tumor effect in osteosarcoma by inducing the endoplasmic reticulum stress response. Cancer Sci 2017;108:1793-802. [PMID: 28643892 DOI: 10.1111/cas.13304] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
64 Li S, Pei Y, Wang W, Liu F, Zheng K, Zhang X. Extracellular nanovesicles-transmitted circular RNA has_circ_0000190 suppresses osteosarcoma progression. J Cell Mol Med 2020;24:2202-14. [PMID: 31923350 DOI: 10.1111/jcmm.14877] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
65 Li J, Guo Z, Wang Z, Fan H, Fu J. Does Microwave Ablation of the Tumor Edge Allow for Joint-sparing Surgery in Patients With Osteosarcoma of the Proximal Tibia? Clin Orthop Relat Res 2015;473:3204-11. [PMID: 26152783 DOI: 10.1007/s11999-015-4447-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
66 Han J, Yong B, Luo C, Tan P, Peng T, Shen J. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China. World J Surg Oncol 2012;10:37. [PMID: 22333159 DOI: 10.1186/1477-7819-10-37] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
67 Topkas E, Cai N, Cumming A, Hazar-Rethinam M, Gannon OM, Burgess M, Saunders NA, Endo-Munoz L. Auranofin is a potent suppressor of osteosarcoma metastasis. Oncotarget 2016;7:831-44. [PMID: 26573231 DOI: 10.18632/oncotarget.5704] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
68 Du GY, He SW, Zhang L, Sun CX, Mi LD, Sun ZG. Hesperidin exhibits in vitro and in vivo antitumor effects in human osteosarcoma MG-63 cells and xenograft mice models via inhibition of cell migration and invasion, cell cycle arrest and induction of mitochondrial-mediated apoptosis. Oncol Lett 2018;16:6299-306. [PMID: 30405765 DOI: 10.3892/ol.2018.9439] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
69 Xu H, Niu X, Zhang Q, Hao L, Ding Y, Liu W, Yao L. Synergistic antitumor efficacy by combining adriamycin with recombinant human endostatin in an osteosarcoma model. Oncol Lett 2011;2:773-8. [PMID: 22866125 DOI: 10.3892/ol.2011.334] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
70 Zhong J, Zhang G, Yao W. Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis. J Orthop Surg Res 2021;16:578. [PMID: 34620208 DOI: 10.1186/s13018-021-02568-2] [Reference Citation Analysis]
71 Lin H, Zhao Z, Hao Y, He J, He J. Long noncoding RNA HIF1A-AS2 facilitates cell survival and migration by sponging miR-33b-5p to modulate SIRT6 expression in osteosarcoma. Biochem Cell Biol 2020;98:284-92. [DOI: 10.1139/bcb-2019-0171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
72 Hassan SE, Bekarev M, Kim MY, Lin J, Piperdi S, Gorlick R, Geller DS. Cell surface receptor expression patterns in osteosarcoma. Cancer 2012;118:740-9. [PMID: 21751203 DOI: 10.1002/cncr.26339] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.4] [Reference Citation Analysis]
73 Wang C, Ba X, Guo Y, Sun D, Jiang H, Li W, Huang Z, Zhou G, Wu S, Zhang J, Chen J. MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma. Sci Rep 2017;7:41456. [PMID: 28120918 DOI: 10.1038/srep41456] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
74 Li Y, Zhou Q, Hu Z, Yang B, Li Q, Wang J, Zheng J, Cao W. 5-Aminolevulinic Acid-Based Sonodynamic Therapy Induces the Apoptosis of Osteosarcoma in Mice. PLoS One 2015;10:e0132074. [PMID: 26161801 DOI: 10.1371/journal.pone.0132074] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
75 Banerjee S, Thayanithy V, Sangwan V, Mackenzie TN, Saluja AK, Subramanian S. Minnelide reduces tumor burden in preclinical models of osteosarcoma. Cancer Lett 2013;335:412-20. [PMID: 23499892 DOI: 10.1016/j.canlet.2013.02.050] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
76 Tao H, Chen F, Liu H, Hu Y, Wang Y, Li H. Wnt/β-catenin signaling pathway activation reverses gemcitabine resistance by attenuating Beclin1-mediated autophagy in the MG63 human osteosarcoma cell line. Mol Med Rep 2017;16:1701-6. [PMID: 28656199 DOI: 10.3892/mmr.2017.6828] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
77 Gill KS, Fernandes P, Bird B, Soden DM, Forde PF. Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma. Oncotarget 2018;9:31473-89. [PMID: 30140384 DOI: 10.18632/oncotarget.25843] [Reference Citation Analysis]
78 Tian Z, Quan X, Xu C, Dan L, Guo H, Leung W. Hematoporphyrin Monomethyl Ether Enhances the Killing Action of Ultrasound on Osteosarcoma In Vivo. Journal of Ultrasound in Medicine 2009;28:1695-702. [DOI: 10.7863/jum.2009.28.12.1695] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
79 Duan Z, Zhang J, Ye S, Shen J, Choy E, Cote G, Harmon D, Mankin H, Hua Y, Zhang Y, Gray NS, Hornicek FJ. A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells. BMC Cancer 2014;14:681. [PMID: 25236161 DOI: 10.1186/1471-2407-14-681] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
80 Zucchini C, Manara MC, Cristalli C, Carrabotta M, Greco S, Pinca RS, Ferrari C, Landuzzi L, Pasello M, Lollini PL, Gambarotti M, Donati DM, Scotlandi K. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity. J Exp Clin Cancer Res 2019;38:503. [PMID: 31878963 DOI: 10.1186/s13046-019-1506-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
81 Duan Z, Ji D, Weinstein EJ, Liu X, Susa M, Choy E, Yang C, Mankin H, Hornicek FJ. Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma. Cancer Lett 2010;293:220-9. [PMID: 20144850 DOI: 10.1016/j.canlet.2010.01.014] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
82 Ma C, Nie XG, Wang YL, Liu XH, Liang X, Zhou QL, Wu DP. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma. Mol Med Rep 2019;19:4205-12. [PMID: 30942427 DOI: 10.3892/mmr.2019.10104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
83 Kawano M, Tanaka K, Itonaga I, Ikeda S, Iwasaki T, Tsumura H. microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells. J Exp Clin Cancer Res 2015;34:76. [PMID: 26243299 DOI: 10.1186/s13046-015-0192-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
84 Choy E, Hornicek F, MacConaill L, Harmon D, Tariq Z, Garraway L, Duan Z. High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes. Cancer 2012;118:2905-14. [PMID: 22006429 DOI: 10.1002/cncr.26617] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
85 Tian Z, Quan X, Leung AW, Xiang J, Xu C. Hematoporphyrin monomethyl ether enhances the killing of ultrasound on osteosarcoma cells involving intracellular reactive oxygen species and calcium ion elevation. Integr Cancer Ther 2010;9:365-9. [PMID: 20702491 DOI: 10.1177/1534735410379013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
86 He H, Ni J, Huang J. Molecular mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett 2014;7:1352-62. [PMID: 24765137 DOI: 10.3892/ol.2014.1935] [Cited by in Crossref: 140] [Cited by in F6Publishing: 135] [Article Influence: 17.5] [Reference Citation Analysis]
87 Chen Z, Xu W, Zhang D, Chu J, Shen S, Ma Y, Wang Q, Liu G, Yao T, Huang Y, Ye H, Wang J, Ma J, Fan S. circCAMSAP1 promotes osteosarcoma progression and metastasis by sponging miR-145-5p and regulating FLI1 expression. Mol Ther Nucleic Acids 2021;23:1120-35. [PMID: 33664993 DOI: 10.1016/j.omtn.2020.12.013] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
88 Mukherjee S, Dash S, Lohitesh K, Chowdhury R. The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells. PLoS One 2017;12:e0179203. [PMID: 28598976 DOI: 10.1371/journal.pone.0179203] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
89 Chen CC, Chueh FS, Peng SF, Huang WW, Tsai CH, Tsai FJ, Huang CY, Tang CH, Yang JS, Hsu YM, Yin MC, Huang YP, Chung JG. Cantharidin decreased viable cell number in human osteosarcoma U-2 OS cells through G2/M phase arrest and induction of cell apoptosis. Biosci Biotechnol Biochem 2019;83:1912-23. [PMID: 31187696 DOI: 10.1080/09168451.2019.1627182] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
90 Chang Z, Huo L, Li K, Wu Y, Hu Z. Blocked autophagy by miR-101 enhances osteosarcoma cell chemosensitivity in vitro. ScientificWorldJournal 2014;2014:794756. [PMID: 25013866 DOI: 10.1155/2014/794756] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
91 Zhang Z, Zhang L, Hua Y, Jia X, Li J, Hu S, Peng X, Yang P, Sun M, Ma F, Cai Z. Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines. BMC Cancer 2010;10:206. [PMID: 20470422 DOI: 10.1186/1471-2407-10-206] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
92 Liu T, Li Z, Zhang Q, De Amorim Bernstein K, Lozano-Calderon S, Choy E, Hornicek FJ, Duan Z. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance. Oncotarget 2016;7:83502-13. [PMID: 27835872 DOI: 10.18632/oncotarget.13148] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
93 Ma J, Niu M, Yang W, Zang L, Xi Y. Role of relaxin-2 in human primary osteosarcoma. Cancer Cell Int 2013;13:59. [PMID: 23758748 DOI: 10.1186/1475-2867-13-59] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
94 Zhang D, Pan X, Ohno S, Osuga T, Sawada S, Sato K. No effects of pulsed electromagnetic fields on expression of cell adhesion molecules (integrin, CD44) and matrix metalloproteinase-2/9 in osteosarcoma cell lines. Bioelectromagnetics 2011;32:463-73. [DOI: 10.1002/bem.20647] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
95 Hsieh M, Hung G, Yen H, Chen W, Chen T. Osteosarcoma in Preadolescent Patients: Experience in a Single Institute in Taiwan. Journal of the Chinese Medical Association 2009;72:455-61. [DOI: 10.1016/s1726-4901(09)70407-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
96 Liu X, Choy E, Hornicek FJ, Yang S, Yang C, Harmon D, Mankin H, Duan Z. ROCK1 as a potential therapeutic target in osteosarcoma. J Orthop Res 2011;29:1259-66. [PMID: 21387396 DOI: 10.1002/jor.21403] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
97 Arima Y, Nobusue H, Saya H. Targeting of cancer stem cells by differentiation therapy. Cancer Sci 2020;111:2689-95. [PMID: 32462706 DOI: 10.1111/cas.14504] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
98 Xu Z, He W, Ke T, Zhang Y, Zhang G. DHRS12 inhibits the proliferation and metastasis of osteosarcoma via Wnt3a/β-catenin pathway. Future Oncol 2020;16:665-74. [PMID: 32250163 DOI: 10.2217/fon-2019-0432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Ma X, Sun W, Shen J, Hua Y, Yin F, Sun M, Cai Z. Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma. Tumor Biol 2016;37:7165-74. [DOI: 10.1007/s13277-015-4565-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
100 Sonaglio V, de Carvalho AC, Toledo SR, Salinas-Souza C, Carvalho AL, Petrilli AS, de Camargo B, Vettore AL. Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcoma. Onco Targets Ther 2013;6:713-23. [PMID: 23836983 DOI: 10.2147/OTT.S44918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
101 Yang M, Yan M, Zhang R, Li J, Luo Z. Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells. Cancer Sci 2011;102:1774-81. [PMID: 21740477 DOI: 10.1111/j.1349-7006.2011.02028.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
102 Zhang Y, Zhao H, Xu W, Jiang D, Huang L, Li L. High Expression of PQBP1 and Low Expression of PCK2 are Associated with Metastasis and Recurrence of Osteosarcoma and Unfavorable Survival Outcomes of the Patients. J Cancer 2019;10:2091-101. [PMID: 31205570 DOI: 10.7150/jca.28480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
103 Gorlick R, Khanna C. Osteosarcoma. J Bone Miner Res 2010;25:683-91. [PMID: 20205169 DOI: 10.1002/jbmr.77] [Cited by in Crossref: 105] [Cited by in F6Publishing: 91] [Article Influence: 8.8] [Reference Citation Analysis]
104 Gao Y, Liao Y, Shen JK, Feng Y, Choy E, Cote G, Harmon D, Mankin HJ, Hornicek FJ, Duan Z. Evaluation of P-glycoprotein (Pgp) expression in human osteosarcoma by high-throughput tissue microarray: P-GLYCOPROTEIN IN OSTEOSARCOMA. J Orthop Res 2016;34:1606-12. [DOI: 10.1002/jor.23173] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
105 Jiang C, Chen H, Shao L, Dong Y. GRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han population. Med Oncol 2014;31:50. [PMID: 24984297 DOI: 10.1007/s12032-014-0050-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
106 Rhee SH, Han I, Lee MR, Cho HS, Oh JH, Kim HS. Role of integrin-linked kinase in osteosarcoma progression. J Orthop Res 2013;31:1668-75. [PMID: 23784942 DOI: 10.1002/jor.22409] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
107 Zhou H, Chen S, Yang Y, Yang C, Chen D, Yao Z, Sun B. Matrine enhances the efficacy of adriamycin chemotherapy in osteosarcoma cells by the STAT3 pathway. Anti-Cancer Drugs 2019;30:1006-12. [DOI: 10.1097/cad.0000000000000796] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Li H, Fu X, Gao Y, Li X, Shen Y, Wang W. Small interfering RNA-mediated silencing of G-protein-coupled receptor 137 inhibits growth of osteosarcoma cells. J Bone Oncol 2018;11:17-22. [PMID: 29321966 DOI: 10.1016/j.jbo.2017.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
109 Zhang K, Wang W, Liu Y, Guo A, Yang D. Let-7b acts as a tumor suppressor in osteosarcoma via targeting IGF1R. Oncol Lett 2019;17:1646-54. [PMID: 30675224 DOI: 10.3892/ol.2018.9793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
110 Shen J, Qu C, Chu H, Cui M, Wang Y, Sun Y, Song Y, Li G, Shi F. siRNA targeting TCTP suppresses osteosarcoma cell growth and induces apoptosis in vitro and in vivo: Role of TCTP in Osteosarcoma. Biotechnology and Applied Biochemistry 2016;63:5-14. [DOI: 10.1002/bab.1335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
111 Meazza C, Asaftei SD. State-of-the-art, approved therapeutics for the pharmacological management of osteosarcoma. Expert Opin Pharmacother 2021;:1-12. [PMID: 34058096 DOI: 10.1080/14656566.2021.1936499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Yu FX, Hu WJ, He B, Zheng YH, Zhang QY, Chen L. Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion. World J Surg Oncol 2015;13:52. [PMID: 25890096 DOI: 10.1186/s12957-015-0465-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
113 Ambroszkiewicz J, Gajewska J, Klepacka T, Chełchowska M, Laskowska-Klita T, Woźniak W. Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma. Adv Med Sci 2010;55:266-72. [PMID: 21084254 DOI: 10.2478/v10039-010-0043-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
114 Ng AJ, Walia MK, Smeets MF, Mutsaers AJ, Sims NA, Purton LE, Walsh NC, Martin TJ, Walkley CR. The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation. PLoS Genet 2015;11:e1005160. [PMID: 25859855 DOI: 10.1371/journal.pgen.1005160] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
115 González-Fernández Y, Imbuluzqueta E, Zalacain M, Mollinedo F, Patiño-García A, Blanco-Prieto MJ. Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells. Cancer Lett 2017;388:262-8. [PMID: 27998763 DOI: 10.1016/j.canlet.2016.12.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
116 Spina A, Sorvillo L, Chiosi E, Esposito A, Di Maiolo F, Sapio L, Caraglia M, Naviglio S. Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells. Oncol Rep. 2013;29:1689-1696. [PMID: 23446517 DOI: 10.3892/or.2013.2306] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
117 Macklin R, Wang H, Loo D, Martin S, Cumming A, Cai N, Lane R, Ponce NS, Topkas E, Inder K, Saunders NA, Endo-Munoz L. Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones. Oncotarget 2016;7:43570-87. [PMID: 27259278 DOI: 10.18632/oncotarget.9781] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
118 Huang R, Xian S, Shi T, Yan P, Hu P, Yin H, Meng T, Huang Z. Evaluating and Predicting the Probability of Death in Patients with Non-Metastatic Osteosarcoma: A Population-Based Study. Med Sci Monit 2019;25:4675-90. [PMID: 31231119 DOI: 10.12659/MSM.915418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Moore C, Eslin D, Levy A, Roberson J, Giusti V, Sutphin R. Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma. Pediatr Blood Cancer 2010;55:1096-102. [PMID: 20734401 DOI: 10.1002/pbc.22673] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
120 Li J, Wang Z, Guo Z, Chen GJ, Yang M, Pei GX. Irregular osteotomy in limb salvage for juxta-articular osteosarcoma under computer-assisted navigation. J Surg Oncol 2012;106:411-6. [PMID: 22442012 DOI: 10.1002/jso.23105] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
121 Zhang W, Zhao W, Li Q, Zhao D, Qu J, Yuan Z, Cheng Z, Zhu X, Zhuang X, Zhang Z. 3D-printing magnesium-polycaprolactone loaded with melatonin inhibits the development of osteosarcoma by regulating cell-in-cell structures. J Nanobiotechnology 2021;19:263. [PMID: 34481503 DOI: 10.1186/s12951-021-01012-1] [Reference Citation Analysis]
122 Chen CH, Li CJ, Tai IC, Lin XH, Hsu HK, Ho ML. The Fractionated Toona sinensis Leaf Extract Induces Apoptosis of Human Osteosarcoma Cells and Inhibits Tumor Growth in a Murine Xenograft Model. Integr Cancer Ther 2017;16:397-405. [PMID: 27879376 DOI: 10.1177/1534735416675951] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
123 Zheng CJ, Yang LL, Liu J, Zhong L. JTC-801 exerts anti-proliferative effects in human osteosarcoma cells by inducing apoptosis. J Recept Signal Transduct Res 2018;38:133-40. [PMID: 29447541 DOI: 10.1080/10799893.2018.1436561] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
124 Wenliang F, Rameli MABP, Ibrahim TAT, Noor MHM, Yusof LM, Zakaria MZAB. In vivo evaluation of anticancer efficacy of drug loaded cockle shell-derived aragonite nanoparticles. J Biomed Mater Res B Appl Biomater 2019;107:1898-907. [PMID: 30597760 DOI: 10.1002/jbm.b.34282] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
125 Frampton JE. Mifamurtide: A Review of its Use in the Treatment of Osteosarcoma. Pediatric Drugs 2010;12:141-53. [DOI: 10.2165/11204910-000000000-00000] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
126 Wang Z, Wang C, Zhou Z, Sun M, Zhou C, Chen J, Yin F, Wang H, Lin B, Zuo D, Li S, Feng L, Duan Z, Cai Z, Hua Y. CD151-mediated adhesion is crucial to osteosarcoma pulmonary metastasis. Oncotarget 2016;7:60623-38. [PMID: 27556355 DOI: 10.18632/oncotarget.11380] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
127 Li M, Lu Y, Long Z, Li M, Kong J, Chen G, Wang Z. Prognostic and clinicopathological significance of circulating tumor cells in osteosarcoma. J Bone Oncol 2019;16:100236. [PMID: 31024791 DOI: 10.1016/j.jbo.2019.100236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
128 Xu J, Wang Z, Liao Z, Dai D, Ma X. MicroRNA-150 functions as an antioncogenic regulator in osteosarcoma. Oncol Lett 2017;14:2483-90. [PMID: 28781686 DOI: 10.3892/ol.2017.6393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
129 Zhao YF, Jiang F, Liang XY, Wei LL, Zhao YY, Ma Q, Hu YS, Su XL. Grifolic acid causes osteosarcoma cell death in vitro and in tumor-bearing mice. Biomed Pharmacother 2018;103:1035-42. [PMID: 29710661 DOI: 10.1016/j.biopha.2018.04.132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
130 Cao R, Shao J, Hu Y, Wang L, Li Z, Sun G, Gao X. microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1. Cancer Cell Int 2018;18:49. [PMID: 29618948 DOI: 10.1186/s12935-018-0551-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
131 Zhou J, Huang Z, Ni X, Lv C. Piperlongumine induces apoptosis and G2/M phase arrest in human osteosarcoma cells by regulating ROS/PI3K/Akt pathway. Toxicol In Vitro 2020;65:104775. [PMID: 31987842 DOI: 10.1016/j.tiv.2020.104775] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
132 Lamora A, Mullard M, Amiaud J, Brion R, Heymann D, Redini F, Verrecchia F. Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases. Oncotarget 2015;6:14413-27. [PMID: 26015407 DOI: 10.18632/oncotarget.3891] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
133 Ho XD, Phung P, Q Le V, H Nguyen V, Reimann E, Prans E, Kõks G, Maasalu K, Le NT, H Trinh L, G Nguyen H, Märtson A, Kõks S. Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples. Exp Biol Med (Maywood) 2017;242:1802-11. [PMID: 29050494 DOI: 10.1177/1535370217736512] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
134 Ren HY, Sun LL, Li HY, Ye ZM. Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data. Biomed Res Int 2015;2015:160835. [PMID: 26618165 DOI: 10.1155/2015/160835] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
135 Nathenson MJ, Sausville E. Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas. Cancer Chemother Pharmacol 2016;78:895-919. [PMID: 27206640 DOI: 10.1007/s00280-016-3055-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
136 Habel N, Stefanovska B, Carène D, Patiño-Garcia A, Lecanda F, Fromigué O. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process. BMC Cancer 2019;19:62. [PMID: 30642298 DOI: 10.1186/s12885-019-5282-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
137 Flanagan AM, Delaney D, O’donnell P. The benefits of molecular pathology in the diagnosis of musculoskeletal disease: Part I of a two-part review: soft tissue tumors. Skeletal Radiol 2010;39:105-15. [DOI: 10.1007/s00256-009-0759-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
138 Alfranca A, Martinez-cruzado L, Tornin J, Abarrategi A, Amaral T, de Alava E, Menendez P, Garcia-castro J, Rodriguez R. Bone microenvironment signals in osteosarcoma development. Cell Mol Life Sci 2015;72:3097-113. [DOI: 10.1007/s00018-015-1918-y] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 12.3] [Reference Citation Analysis]
139 Dutour A, Josserand V, Jury D, Guillermet S, Decouvelaere AV, Chotel F, Pointecouteau T, Rizo P, Coll JL, Blay JY. Targeted imaging of αvβ3 expressing sarcoma tumor cells in vivo in pre-operative setting using near infrared: A potential tool to reduce incomplete surgical resection. Bone 2014;62:71-8. [DOI: 10.1016/j.bone.2014.02.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
140 Yarapureddy S, Abril J, Foote J, Kumar S, Asad O, Sharath V, Faraj J, Daniel D, Dickman P, White-Collins A, Hingorani P, Sertil AR. ATF6α Activation Enhances Survival against Chemotherapy and Serves as a Prognostic Indicator in Osteosarcoma. Neoplasia 2019;21:516-32. [PMID: 31029032 DOI: 10.1016/j.neo.2019.02.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
141 Teicher BA, Polley E, Kunkel M, Evans D, Silvers T, Delosh R, Laudeman J, Ogle C, Reinhart R, Selby M, Connelly J, Harris E, Monks A, Morris J. Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression. Mol Cancer Ther 2015;14:2452-62. [PMID: 26351324 DOI: 10.1158/1535-7163.MCT-15-0074] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
142 Zhao YX, Gao ST, Wang JQ, Yao WT, Wang YS, Guo CL. Correlations Between Hector Battifora Mesothelial-1 (HBME-1) Expression and Clinical Pathological Characteristics and Prognosis of Osteosarcoma Patients. Med Sci Monit 2017;23:665-72. [PMID: 28163298 DOI: 10.12659/msm.898820] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
143 Guais A, Baronzio G, Sanders E, Campion F, Mainini C, Fiorentini G, Montagnani F, Behzadi M, Schwartz L, Abolhassani M. Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report. Invest New Drugs. 2012;30:200-211. [PMID: 20931262 DOI: 10.1007/s10637-010-9552-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
144 Cao Y, Roth M, Piperdi S, Montoya K, Sowers R, Rao P, Geller D, Houghton P, Kolb EA, Gill J, Gorlick R. Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma. PLoS One 2014;9:e106249. [PMID: 25170759 DOI: 10.1371/journal.pone.0106249] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
145 Wu J, Guo A, Li Q, Wang D. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma. Future Oncol 2017;13:1883-91. [PMID: 28766969 DOI: 10.2217/fon-2017-0180] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
146 Qin YG, Zhu LY, Wang CY, Zhang BY, Wang QY, Li RY, Liu Z. Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma. Lipids Health Dis 2015;14:70. [PMID: 26170203 DOI: 10.1186/s12944-015-0068-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
147 Jiang X, Zhang Z, Song C, Deng H, Yang R, Zhou L, Sun Y, Zhang Q. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma. Chem Biol Interact 2019;307:158-66. [PMID: 31059706 DOI: 10.1016/j.cbi.2019.05.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
148 Han J, Yu Y, Wu S, Wang Z, Zhang W, Zhao M, Yao Y, Hu Y, Wang W, Liu X, Yu W, Cheng J, Yu L, Bao Q, Zhang G, Yu X, Song R. Clinical factors affecting prognosis of limb osteosarcoma in China: a multicenter retrospective analysis. J Int Med Res 2020;48:300060520930856. [PMID: 32865070 DOI: 10.1177/0300060520920053] [Reference Citation Analysis]
149 He N, Zhang Z. Baicalein suppresses the viability of MG-63 osteosarcoma cells through inhibiting c-MYC expression via Wnt signaling pathway. Mol Cell Biochem 2015;405:187-96. [PMID: 25893737 DOI: 10.1007/s11010-015-2410-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
150 Lemma S, Avnet S, Meade MJ, Chano T, Baldini N. Validation of Suitable Housekeeping Genes for the Normalization of mRNA Expression for Studying Tumor Acidosis. Int J Mol Sci 2018;19:E2930. [PMID: 30261649 DOI: 10.3390/ijms19102930] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
151 Ying M, Liu G, Shimada H, Ding W, May WA, He Q, Adams GB, Wu L. Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity. Oncogene 2013;32:4252-63. [PMID: 23045288 DOI: 10.1038/onc.2012.438] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
152 Lillo Osuna MA, Garcia-Lopez J, El Ayachi I, Fatima I, Khalid AB, Kumpati J, Slayden AV, Seagroves TN, Miranda-Carboni GA, Krum SA. Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis. Cancer Res 2019;79:1054-68. [PMID: 30593524 DOI: 10.1158/0008-5472.CAN-18-1255] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
153 Gai P, Sun H, Wang G, Xu Q, Qi X, Zhang Z, Jiang L. miR-22 promotes apoptosis of osteosarcoma cells via inducing cell cycle arrest. Oncol Lett 2017;13:2354-8. [PMID: 28454403 DOI: 10.3892/ol.2017.5674] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
154 Mishra R, Nathani S, Varshney R, Sircar D, Roy P. Berberine reverses epithelial-mesenchymal transition and modulates histone methylation in osteosarcoma cells. Mol Biol Rep 2020;47:8499-511. [PMID: 33074411 DOI: 10.1007/s11033-020-05892-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
155 Kohama I, Asano N, Matsuzaki J, Yamamoto Y, Yamamoto T, Takahashi RU, Kobayashi E, Takizawa S, Sakamoto H, Kato K, Fujimoto H, Chikuda H, Kawai A, Ochiya T. Comprehensive serum and tissue microRNA profiling in dedifferentiated liposarcoma. Oncol Lett 2021;22:623. [PMID: 34285721 DOI: 10.3892/ol.2021.12884] [Reference Citation Analysis]
156 Yang W, He M, Zhao J, Wang Z. Association of ITGA3 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma. Med Oncol 2014;31:826. [PMID: 24381140 DOI: 10.1007/s12032-013-0826-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
157 Scharschmidt T, Cohen A, Thomas N, Ching R, Conrad E. Torsional Stability of Uncemented Femoral Stems in Oncologic Reconstructions. Orthopedics 2011;34. [DOI: 10.3928/01477447-20101221-13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Tempelaere C, Biau D, Babinet A, Anract P. Osteosarcoma after the age of fifty: A clinicopathological study. Eur J Surg Oncol 2019;45:1288-92. [PMID: 31014986 DOI: 10.1016/j.ejso.2019.04.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Li S, Pei Y, Wang W, Liu F, Zheng K, Zhang X. Circular RNA 0001785 regulates the pathogenesis of osteosarcoma as a ceRNA by sponging miR-1200 to upregulate HOXB2. Cell Cycle 2019;18:1281-91. [PMID: 31116090 DOI: 10.1080/15384101.2019.1618127] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
160 Yang S, Wang B, Liu C, Wang Q, Wang R, Su W, Zhu Y, Li M, Guo Z, Wu X, Chen F. THAP9-AS1 Promotes Tumorigenesis and Reduces ROS Generation through the JAK2/STAT3 Signaling Pathway by Increasing SOCS3 Promoter Methylation in Osteosarcoma. Oxid Med Cell Longev 2021;2021:5620475. [PMID: 34691358 DOI: 10.1155/2021/5620475] [Reference Citation Analysis]
161 Huang Q, Chen C, Lou J, Huang Y, Ren T, Guo W. Development of a Nomogram for Predicting the Efficacy of Preoperative Chemotherapy in Osteosarcoma. Int J Gen Med 2021;14:4819-27. [PMID: 34475776 DOI: 10.2147/IJGM.S328991] [Reference Citation Analysis]
162 Prasad SR, Kumar TSS, Jayakrishnan A. Nanocarrier-based drug delivery systems for bone cancer therapy: a review. Biomed Mater 2021;16. [PMID: 33853043 DOI: 10.1088/1748-605X/abf7d5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Meazza C, Scanagatta P. Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Rev Anticancer Ther 2016;16:543-56. [PMID: 26999418 DOI: 10.1586/14737140.2016.1168697] [Cited by in Crossref: 91] [Cited by in F6Publishing: 97] [Article Influence: 15.2] [Reference Citation Analysis]
164 Wang X, Liu Z. Systematic meta-analysis of genetic variants associated with osteosarcoma susceptibility. Medicine (Baltimore) 2018;97:e12525. [PMID: 30235774 DOI: 10.1097/MD.0000000000012525] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
165 Zhou W, Zhu Y, Chen S, Xu R, Wang K. Fibroblast growth factor receptor 1 promotes MG63 cell proliferation and is associated with increased expression of cyclin-dependent kinase 1 in osteosarcoma. Mol Med Rep 2016;13:713-9. [PMID: 26648125 DOI: 10.3892/mmr.2015.4597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
166 Hattinger CM, Pasello M, Ferrari S, Picci P, Serra M. Emerging drugs for high-grade osteosarcoma. Expert Opin Emerg Drugs 2010;15:615-34. [PMID: 20690888 DOI: 10.1517/14728214.2010.505603] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]